Scientists discovered that certain cancer cells use a low-level activation of a DNA-dismantling enzyme—normally seen in cell death—to survive treatment. Instead of dying, these “persister cells” leverage this sublethal signal to regrow. Because the mechanism is non-genetic, it appears much earlier than typical resistance mutations. Targeting this enzyme could help stop tumors from returning.
source https://www.sciencedaily.com/releases/2025/12/251210092022.htm
Flashback: The 2016 Chrome and Android‑apps story that predicted today’s
Googlebooks moment
-
A 2016 warning about Android apps on Chrome feels newly relevant as
Googlebooks pushes Android PCs into the agentic era and challenges
Microsoft again.
s...
2 hours ago
No comments:
Post a Comment